cnto 2476
Cell therapyexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2007 (NCT00458575)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cnto 2476
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02895815 | Phase 2 | Apr 9, 2018 | Janssen Pharmaceutica NV |
| NCT02659098 | Phase 2 | Mar 21, 2016 | Johnson and Johnson |
| NCT01226628 | Phase 1/Phase 2 (Phase 2) | Oct 21, 2010 | Johnson and Johnson |
| NCT00458575 | Phase 1 | Apr 1, 2007 | Centocor |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 2 | 2 | 1 | 2010 |
| Centocor | For profit | 1 | 1 | 1 | 2007 |
| Janssen Pharmaceutica NV | For profit | 1 | 1 | 1 | 2018 |
3 organizations
Page 1 / 1